중재 시술의 발전으로, 노출된 방사선으로 인한 의료 방사선 중재 시술자에 미치는 건강 위협이 증대됨에 따라 시술 중 방사선 노출을 최소화하기 위한 관심과 노력이 요구되고 있다. 이에 대한췌장담도학회에서는 투시 장비를 이용한 중재 시술 중 의료 방사선 중재 시술자에게 미치는 방사선 노출을 최소화하기 위한 권고안을 개발하였다. 본 권고안은 방사선 차폐, 방사선 투시기와 방사선량의 관리, 방사선 노출 선량 한도 및 감시, 임신과 출산 총 4가지 분야로 나누어 중재 시술자에게 방사선 노출의 위험을 이해하기 위한 지식을 전달하고 실질적으로 수행해야 하는 권고사항을 명확히 제시하여 불필요한 방사선 노출을 피하기 위한 실용적인 접근이 가능하도록 구성되었다. 본 권고안을 통해 의료 방사선 중재시술자의 방사선 노출을 최소화하여 안전하고 효과적인 중재 시술이 이루어질 수 있기를 기대한다.

Traditional building technique has been used as the main technology in the field of architectural heritage conservation in South Korea. It has remained this way with very little resistance until now. But the time has come to question the appropriateness of traditional technique as conservation technique. In this paper a study was done on the properties of the traditional technique and the architectural heritage conservation technique in order to define the appropriateness between the two techniques. As a result the traditional technique was found to be unfit for conservation technique. The reasons are as follows. First, there is a time gap between the traditional technique and the time when the heritage was first built. Second, conservation work is about retaining the values of being a heritage while the traditional technique is about safeness and practicality. Third, the use of traditional technique comes with using the tools of its time which cannot ensure the safety of the heritage. The traditional technique must be looked upon as one of an option in the field of conservation. We must develop a better conservation technology by finding balance between the traditional technique and modern science. And further more an aggressive investment must be made in order to realize this objective.

Telangiectatic osteosarcoma(TAEOS) is a rare subtype of osteosarcoma(OS) composed of blood-filled or empty cystic architecture simulating aneurysmal bone cyst. TAEOSs account for 2-12% of all OSs. TAEOSs mostly develop around knee and proximal humerus, but TAEOSs of the jaws are rare. To the best of my knowledge, this is the fourth case of primary TAEOS affecting the jaws. A 36-year-old female who had been previously diagnosed osteosarcoma by biopsy reported with a chief complaint of throbbing and swelling of the right mandible. The patient received neoadjuvant chemotherapy followed by hemi-mandibulectomy. After surgery, patient received adjuvant chemotherapy. The patient is free of disease for 6 months after surgery. TAEOSs are mimicking other benign entities, such as aneurysmal bone cyst and central giant cell granuloma. Thus, careful diagnosis through thorough radiographic and histopathologic evaluation is important to establish a treatment plan, prognosis, prediction and management strategy.

It is well documented that giant cells can be observed in some types of odontogenic tumors such as central odontogenic tumor and dentinogenic ghost cell tumor. However, the presence of stromal giant cells has only rarely been reported in ameloblastoma, although being the most common epithelial odontogenic tumor. In this study, we present a novel case of peripheral ameloblastoma associated with peripheral giant cell granuloma arising in the mandibular alveolar mucosa of a 65-year-old male patient. The possible pathogenesis of this combined lesion will be discussed, in addition to the review of previous reports of ameloblastoma accompanied by stromal giant cells.

Sarcomatous transformation of fibrous dysplasia (FD) is rare and can occur in patients with McCune-Albright syndrome (MAS). To date, there have been several cases of malignant transformation of FD in the craniofacial area of patients with MAS. Here, we report an additional case of secondary osteosarcoma arising from FD in the mandible of a 41-year-old woman with MAS. The patient complained of rapid swelling in the right facial area, which was initially misdiagnosed as soft tissue sarcoma at another hospital. After neoadjuvant concurrent chemoradiotherapy resulting in poor response, the lesion was surgically resected in our hospital, and the final diagnosis of secondary osteosarcoma was rendered. Currently, post-operative adjuvant chemotherapy is in progress. As a result of our review of 17 reported cases showing malignant transformation in FD/MAS, the M/F ratio was 1:1.1, and the median age at onset of malignancy was 28.6 years. The most commonly affected site was the craniofacial bones (n=13; 76%), and the most common histopathologic type of malignancy was osteosarcoma (n=14; 82%). More than half of the patients (8/15; 53.3%) died within 1 year, mainly due to lung metastasis (6/8; 75%). Taken together, since MAS patients with malignant transformation of FD have a relatively poor prognosis, accurate diagnosis based on histopathologic findings as well as clinical and radiographic information is important to select optimal treatment.

췌장고형종양의 초음파 내시경(endoscopic ultrasound, EUS) 유도하 조직 검사는 기술적 난이도가 높고 침습적이기 때문에 임상에서의 적절한 사용을 위해 엄격한 권고안을 필요로 한다. 이에 대한소화기내시경학회에서는 췌장고형종양의 초음파 내시경 유도하 조직 검사를 위한 임상진료지침을 개발하기 위해 진료지침 개발위원회를 발족하였다. 권고안의 등급과 개별 권고안의 근거 수준은 2014년 출판된 임상진료지침 개발을 위한 Minds Handbook에서 제시된 체계에 기반하여 평가하였다. 본 진료지침 개발위원회는 초음파 내시경 분야의 전문가 16인과 임상진료지침 개발방법론 전문가 1인으로 구성되었으며, 8개 분야에 걸쳐 총 12건의 근거 기반 권고안을 개발하여 췌장고형종양 진단 시 임상의들이 근거에 기반한 임상적 판단을 할 수 있도록 돕고자 하였다. 본 임상 진료지침은 췌장고형종양에서 초음파 내시경 유도하 조직 검사에 대해 다루고 있으며, 권고안에서는 해당 검사의 적응증, 진단 정확도를 최대화하기 위한 기술적 방법론(예: 바늘의 종류 및 직경의 적절한 선택, 충분한 바늘천자횟수, 조직 획득 기술적 방법론, 검체 처리 방법), 시술 관련 합병증, 그리고 숙련도와 교육에 관련된 문제들에 대해 다루고 있다. 본 진료지침은 외부 전문가의 검토를 거쳤으며, 원고작성 시점까지 보고된 가능한 모든 최신 근거들에 기반하여 최선의 진료 방법을 권고하고 있다. 그러나 모든 임상 상황에 본 진료지침을 일괄적으로 적용할 수는 없으며, 기관의 법적/행정적 상황 및 환자의 개별 임상적 상황과 해당 자원의 가용성 등을 고려하여야 한다. 추후 내시경적 기술의 발전과 이로 인한 변화, 임상에서의 최신 근거를 토대로 본 진료지침이 개정될 수 있다.

This study is to evaluate the prior economic feasibility of the off-shore fisheries stock enhancement project. The main findings of this study can be summarized as follows: first, offshore fisheries stock enhancement project shall be implemented by dividing them into 1st·2nd·3rd projects for efficient promotion. The 1st·2nd·3rd projects will be conducted in a total of 50 locations (the eastern sea, the western sea, the southern sea, and the jeju sea areas), and the project period per unit will be five years, which will cost 1 trillion won. Second, according to the results of the survey on public awareness, the most consumed marine species in Korea over the past year were analyzed in the order of mackerel, hairtail, squid, yellow corvina, blue crab, and cod. The dominant response to the reason for consuming marine products in Korea was healthy well-being food and safe food. In addition, 67.9% of them have hesitated to purchase offshore fish species over the past year due to high prices, indicating that they are burdened by high prices. On the other hand, 79% of the respondents said that the government’s policy was insufficient, according to a survey on whether the government's coastal marine resource creation policy was sufficient. Third, as a result of preliminary economic analysis of offshore fisheries stock enhancement project, the benefit-cost ratio is 4.01, net present price is 1,283.7 billion won, and internal rate of return is 91.7% per year, which means that the economic analysis ensures the feasibility of the projects. The results of this study provide useful information on securing or organizing budgets for offshore fisheries stock enhancement project by securing economic feasibility as a national infrastructure project that increases fishery income and public benefits such as consumption of marine products.

초고성능 콘크리트(UHPC)는 낮은 물-결합재비(W/B), 고성능 감수제(SP), 혼화재 및 강섬유(Steel Fiber)의 혼입으로 일반 콘크리트보다 유동성, 강도 등에서 월등히 우수한 성능을 지닌 건설 재료이다. 본 연구에서는 진동밀로 분쇄하여 시멘트의 분말도를 6000cm2/g급 까지 높여 최적의 초고성능 모르타르를 제작하였다. 또한, UHPC의 특성상 시멘트, 혼화재뿐만 아니라 화학 혼화제 혼입량에 따라 물성에 많은 차이를 나타내기 때문에 최적의 화학 혼화제를 도출하기 위하여 고성능 혼화제에 따른 물성 평가 실험도 수행하였다. 분쇄된 시멘트를 활용한 초고성능 모르타르의 유동성, 강도 등 물성 테스트를 진행하였으며, 경제성을 고려하여 강섬유와 기타 혼화재를 혼입하지 않고 목표 물성을 달성하고자 하였다. 실험결과, 모든배합에서 플로우 값은 목표치 180±10mm를 확보하였으며, W/B 20%, SP 0.8%에서 최대 압축강도 90MPa, 휨강도 16.8MPa까지 나타났다.